Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
Open Access
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 141, 111815
Abstract
No abstract availableKeywords
Funding Information
- University of Arkansas for Medical Sciences
- Narodowe Centrum Nauki (2016/23/D/ST5/00242)
- Ministerstwo Edukacji i Nauki (STYP/15/1665/E-336/2020)
- Narodowa Agencja Wymiany Akademickiej (2019/32/U/ST4/00092)
- Narodowa Agencja Wymiany Akademickiej (PPN/BEK/2019/1/00034)
- National Cancer Institute
This publication has 93 references indexed in Scilit:
- Understanding and targeting cancer stem cells: therapeutic implications and challengesActa Pharmacologica Sinica, 2013
- Salinomycin as a Drug for Targeting Human Cancer Stem CellsJournal of Biomedicine and Biotechnology, 2012
- Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cellsProceedings of the National Academy of Sciences, 2011
- Eaten alive: a history of macroautophagyNature Cell Biology, 2010
- Autophagy: cellular and molecular mechanismsThe Journal of Pathology, 2010
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput ScreeningCell, 2009
- Enhancement of Docetaxel Anticancer Activity by a Novel Diindolylmethane Compound in Human Non–Small Cell Lung CancerClinical Cancer Research, 2009
- Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal TransitionPLOS ONE, 2008
- The Hallmarks of CancerCell, 2000
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990